Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Medullary × temsirolimus × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 11 Sarcoma 6 Neoplasms 5 Rhabdomyosarcoma 4 Lymphoma, Mantle-Cell 4 Kidney Neoplasms 4 Osteosarcoma 3 Neoplasm Metastasis 3 Melanoma 3 Endometrial Neoplasms 3 Breast Neoplasms 3 Waldenstrom Macroglobulinemia 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Liposarcoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Gliosarcoma 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1

Interventions

vandetanib 9 cabozantinib 4 selpercatinib 3 Sunitinib 2 Sorafenib 2 yeast-CEA vaccine 1 tanespimycin 1 pralsetinib 1 pembrolizumab 1 pazopanib 1 lenvatinib 1 Vorinostat 1 Temozolomide 1 Pharmacogenomic Testing 1 Magnetic Resonance Spectroscopy 1 Lithium Carbonate 1 Irinotecan 1 Gefitinib 1 Ferrosoferric Oxide 1 Capecitabine 1 Bortezomib 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡